Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yutong Chen's publication output changed over time?
ScholarIQpublication output · 2009–2024
Output grew0% over the shown period — from 1 works in 2009 to 1 in 2024.
1
1
1
1
3
3
1
2009201720192021202220232024
What are the most-cited papers on Yutong Chen?
ScholarIQmost cited works
AI-Based Reconstruction for Fast MRI—A Systematic Review and Meta-Analysis
Yutong Chen, Carola‐Bibiane Schönlieb, Píetro Lió, Tim Leiner, Pier Luigi Dragotti, Ge Wang, Daniel Rueckert, David Firmin, Guang Yang
S68686220. 2022118 CitationsOPEN ACCESS
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Shihao Su, Yutong Chen, Pengfei Zhang, Ruijuan Ma, Wei Zhang, Jianing Liu, Tao Li, Hanjing Niu, Yi Cao, Bin Hu, Jin-Hua Gao, Hua Sun, Dong Fang, Jiajia Wang, Peng George Wang, Songqiang Xie, Chaojie Wang, Jing Ma
S4210169613. 202261 Citations
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways
Yao Liu, Xin Guan, Meiling Wang, Naixue Wang, Yutong Chen, Baolei Li, Zhuxuan Xu, Fu Fangwei, Cheng Du, Zhendong Zheng
S4210193419. 202254 CitationsOPEN ACCESS
TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy
Weiyu Zhang, Yao Tang, Pengfei Yang, Yutong Chen, Zhijie Xu, Chunhui Qi, Hongbin Huang, Ruiyang Liu, Haorui Qin, Haoying Ke, Caini Huang, Fuyuan Xu, Pengfei Pang, Zhiju Zhao, Hong Shan, Fei Xiao
S102544370. 202432 CitationsOPEN ACCESS
Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers
Shu-Fen Mo, Zeng-Zhi Cai, Wen-Hao Kuai, Xuexin Li, Yutong Chen
S2596924766. 202326 CitationsOPEN ACCESS
Related on ScholarIQ
Zhejiang Chinese Medical University
Institution
AI-Based Reconstruction for Fast MRI—A Systematic Review and Meta-Analysis
Paper
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Paper
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways
Paper
TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy
Paper
Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers
Paper